Published in J Am Coll Cardiol on March 02, 2010
Gene therapy for cardiovascular disease mediated by ultrasound and microbubbles. Cardiovasc Ultrasound (2013) 0.80
Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med (2014) 9.33
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest (2003) 3.19
Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation (2013) 2.08
Thymosin beta4 is an essential paracrine factor of embryonic endothelial progenitor cell-mediated cardioprotection. Circulation (2008) 1.77
Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia. J Am Coll Cardiol (2003) 1.62
Three-dimensional printing of models for preoperative planning and simulation of transcatheter valve replacement. Ann Thorac Surg (2012) 1.46
Myocardial transfection of hypoxia inducible factor-1alpha via an adenoviral vector during coronary artery bypass grafting. - A multicenter phase I and safety study -. Circ J (2010) 1.46
Transcutaneous aortic valve replacement with the Edwards SAPIEN XT and Medtronic CoreValve prosthesis under fluoroscopic guidance and local anaesthesia only. Heart (2014) 1.43
Angiopoietin 2 mediates microvascular and hemodynamic alterations in sepsis. J Clin Invest (2013) 1.32
Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation (2013) 1.31
RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood (2010) 1.14
Transgenic expression of the human A20 gene in cloned pigs provides protection against apoptotic and inflammatory stimuli. Xenotransplantation (2009) 1.07
Transcatheter Edwards Sapien XT valve in valve implantation in degenerated aortic bioprostheses via transfemoral access. Clin Res Cardiol (2012) 1.06
Reduction of pacemaker implantation rates after CoreValve® implantation by moderate predilatation. EuroIntervention (2014) 1.05
Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins: comparison with surgical and percutaneous intramyocardial gene delivery. J Am Coll Cardiol (2004) 1.03
Edwards Sapien XT valve placement as treatment option for aortic regurgitation after transfemoral CoreValve implantation: a multicenter experience. Clin Res Cardiol (2013) 1.03
Accuracy of dynamic computed tomography adenosine stress myocardial perfusion imaging in estimating myocardial blood flow at various degrees of coronary artery stenosis using a porcine animal model. Invest Radiol (2012) 0.98
Mitochondrial thioredoxin reductase is essential for early postischemic myocardial protection. Circulation (2011) 0.95
Gene therapy for ischemic heart disease. Expert Opin Biol Ther (2011) 0.94
Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia. PLoS One (2013) 0.92
Feasibility of dynamic CT-based adenosine stress myocardial perfusion imaging to detect and differentiate ischemic and infarcted myocardium in an large experimental porcine animal model. Int J Cardiovasc Imaging (2014) 0.89
Sick sinus syndrome in HCN1-deficient mice. Circulation (2013) 0.89
Role of PARP on iNOS pathway during endotoxin-induced acute lung injury. Intensive Care Med (2004) 0.88
Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia. Ann N Y Acad Sci (2010) 0.86
Proinflammatory role of inducible nitric oxide synthase in acute hyperoxic lung injury. Respir Res (2004) 0.85
Retroinfusion-supported stenting in high-risk patients for percutaneous intervention and bypass surgery: results of the prospective randomized myoprotect I study. Catheter Cardiovasc Interv (2004) 0.84
SDF-1 fused to a fractalkine stalk and a GPI anchor enables functional neovascularization. Stem Cells (2013) 0.84
Effectiveness of automated quantification of pulmonary perfused blood volume using dual-energy CTPA for the severity assessment of acute pulmonary embolism. Invest Radiol (2013) 0.83
NF kappaB activation in embryonic endothelial progenitor cells enhances neovascularization via PSGL-1 mediated recruitment: novel role for LL37. Stem Cells (2010) 0.83
Molecular and cellular mechanisms of thymosin β4-mediated cardioprotection. Ann N Y Acad Sci (2012) 0.82
Liposomal Hsp90 cDNA induces neovascularization via nitric oxide in chronic ischemia. Cardiovasc Res (2005) 0.82
Current concepts and applications of coronary venous retroinfusion. Basic Res Cardiol (2004) 0.81
Percutaneous approach to a stent-based ventricle to coronary vein bypass (venous VPASS): comparison to catheter-based selective pressure-regulated retro-infusion of the coronary vein. Eur Heart J (2005) 0.80
Adjuvant early and late cardioprotective therapy: access to the heart. Cardiovasc Res (2012) 0.78
Thymosin β4 attenuates microcirculatory and hemodynamic destabilization in sepsis. Expert Opin Biol Ther (2015) 0.78
Therapeutic angiogenesis/arteriogenesis in the chronic ischemic rabbit hindlimb: effect of venous basic fibroblast growth factor retroinfusion. Endothelium (2003) 0.77
Recombinant adeno-associated virus-based gene transfer of cathelicidin induces therapeutic neovascularization preferentially via potent collateral growth. Hum Gene Ther (2009) 0.77
Attenuation of cardiac hypertrophy by G-CSF is associated with enhanced migration of bone marrow-derived cells. J Cell Mol Med (2015) 0.77
Preconditioned endothelial progenitor cells reduce formation of melanoma metastases through SPARC-driven cell-cell interactions and endocytosis. Cancer Res (2011) 0.77
Partial inferior sternotomy and deep hypothermic circulatory arrest for rescue of a failed TAVI case: what does constitute 'inoperable'? Thorac Cardiovasc Surg (2013) 0.77
Adeno-associated viral vector 2.9 thymosin ß4 application attenuates rejection after heart transplantation: results of a preclinical study in the pig. Transplantation (2014) 0.76
Targeting microRNAs for cardiovascular therapeutics in coronary artery disease. Curr Opin Cardiol (2014) 0.76
Angiogenetic potential of Ad2/Hif-1α/VP16 after regional application in a preclinical pig model of chronic ischemia. Curr Vasc Pharmacol (2013) 0.76
Transcatheter aortic valve implantation in dialysis patients. Nephron Clin Pract (2012) 0.76
Transfemoral access for valve in valve implantation of an Edwards Sapien XT valve in a stenotic tricuspid bioprosthesis under fluoroscopic guidance. Can J Cardiol (2013) 0.75
Balloon valvuloplasty for treatment of cardiogenic shock in the era of surgical valve replacement and TAVI. Intern Emerg Med (2013) 0.75
Hemodynamic and vascular effects of ventricular sourcing by stent-based ventricle to coronary artery bypass in patients with multivessel disease undergoing coronary artery bypass surgery. Circulation (2005) 0.75
Corrigendum: Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. Nat Commun (2017) 0.75
[Role of bone marrow-derived CD133+ stem cells in cardiac regeneration: from experimental to clinical trials]. G Ital Cardiol (Rome) (2014) 0.75
Partial avulsion of prosthetic aortic valve caused by S. epidermidis infection resulting in a giant false aneurysm of the complete thoracic aorta. Int J Cardiol (2010) 0.75
Transcatheter aortic-valve endocarditis confirmed by transesophageal echocardiography. Circulation (2013) 0.75
Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation. EuroIntervention (2015) 0.75
Thymosin-β4-mediated therapeutic neovascularization: role of the PI3K/AKT pathway. Expert Opin Biol Ther (2015) 0.75
Transcatheter aortic valve implantation in aortic coarctation. Thorac Cardiovasc Surg (2012) 0.75